units (ICUs). We investigated whether ICU-acquired BSI increased mortality (by у10%) after adjustment for severity of infection at ICU admission and during the pre-BSI stay.
invasive health care procedures conspire to create a high risk of nosocomial BSI in critically ill patients. Outcomes of BSI have been the focus of many case-control and cohort studies [1] [2] [3] [4] [5] [6] [7] . Two studies [1, 2] published 5 years apart found a remarkably similar 35% attributable mortality for nosocomial BSI, whereas no impact on mortality was noted in studies focusing on specific bacterial species [3] [4] [5] [6] [7] or on catheter-related BSI [8] . Possible causes of discrepancies across studies may include differences in populations, BSIs, and methods used to account for severity of illness. Because severity of the acute illness may act as a potent confounder, effective adjustment for this factor is imperative. General severity scores (Simplified Acute Physiology Score [SAPS] II, APACHE II, and Mortality Predicted Model 24 [MPM24]) [9] [10] [11] [12] [13] are often used to match patients with and without BSI [3] [4] [5] [6] [7] . However, many studies have found these scores to be inaccurate after the third ICU day [14] [15] [16] [17] [18] , which is the time interval used to define nosocomial infections. Several studies have suggested [18] [19] [20] [21] [22] [23] that the course from ICU admission to nosocomial infection may predict mortality independent of severity at admission and may differ significantly between patients who do and do not experience nosocomial infection [20, 21] . Finally, the studies that found no effect of nosocomial BSI on mortality [8, 21] did not have sufficient statistical power to detect a small increase in mortality. Because nosocomial BSI could be used as an indicator of quality of care for benchmarking ICUs, determining the exact impact of BSI on outcome is of considerable importance.
The primary objective of this study was to test the hypothesis that ICU-acquired BSI is associated with a у10% increase in the risk of death among exposed patients (i.e., patients with ICU stays 13 days), when both severity and the time-course of severity prior to onset of BSI are taken into account. The secondary objective was to investigate the influence of several covariates on mortality from ICU-acquired BSI.
METHODS

The Outcomerea Database
We conducted an observational study using the multicenter database OUTCOMEREA, which contains data from 12 ICUs in France. A convenience sample of patients 118 years old who were admitted between January 1997 and April 2004 for 124 h was obtained.
Briefly, each ICU could have chosen 1 of 2 methods to select the patient sample: (1) patients consecutively admitted to ICU beds or (2) patients consecutively admitted in a given month. The allocation of beds (or month) is determined yearly by the database steering committee. All 12 ICUs implement full barrier precautions during intravascular catheter insertion. Site preparation was performed with 10% povidone-iodine solution. Central venous catheters were changed only when infection was suspected. Neither coated catheters nor selective digestive decontamination were used. Nurses performed peripheral blood cultures routinely for patients with a body temperature 138.5ЊC or chills, in addition to the blood cultures ordered by attending physicians. Antibiotic treatment of nosocomial infections was administered at the discretion of the attending intensivist.
Data collection. Data were collected daily on computers by ICU physicians closely involved in the creation of the database. All codes and definitions were written before data were collected. For each patient, the ICU physician completed a casereport form on a computer using data-capture software (VI-GIREA [OUTCOMEREA]) then imported all records into the database. The following information was recorded prospectively: demographic characteristics (age, sex, weight, and height); underlying diseases (determined by the McCabe score [24] and Knaus classification [25] ); presence of diabetes mellitus (including type and complications); admission category (medical, scheduled surgery, or unscheduled surgery); admission diagnosis (cardiac, respiratory, or neurologic failure, infection, and other); invasive procedures (arterial or venous central catheter, Swan-Ganz catheter, or endotracheal intubation); and treatment of organ failures (inotropic support, hemodialysis, and mechanical ventilation). Location of the patient prior to ICU admission was recorded, with transfer from a ward defined as being in the same hospital or another hospital before ICU admission. Severity of illness was recorded at admission and on each day. Day 1 was defined as the period of time from admission to 8 a.m.. on the next day; all other days were calendar days counted from 8 a.m. to 8 a.m. SAPS II [9] was computed at admission using physical and laboratory data most indicative of disease severity during the first 24 h in the ICU. The SAPS II [9] and the Logistic Organ Dysfunction (LOD) score [26] were computed daily. The Three-day Recalibrated ICU Outcome score (TRIO) [16] was calculated; this score, specifically designed and validated for patients with ICU stays 13 days, predicts hospital mortality on the basis of chronic illnesses, location prior to ICU admission, SAPS II and LOD score at ICU admission, and changes in SAPS II and LOD scores over the first 3 days spent in the ICU. Duration of stay in the ICU and acute-care hospital and vital status at discharge from the ICU and hospital were recorded.
Positive blood culture results, microorganisms, resistance to antimicrobials, portals of entry, and antimicrobials received were recorded prospectively by attending physicians. The treatment of BSI was considered to be appropriate when a regimen including at least 1 antimicrobial effective in vitro was initiated on the sampling day or on the next day. The date on which appropriate antimicrobial therapy was initiated was recorded.
Quality of the database. Quality was checked in 2003 by reviewing a random 2% sample of the data recorded in each ICU. This was done by intensivists from other ICUs. Interrater correlation coefficients ranged from 0.67 to 1 for clinical variables and for severity and organ dysfunction scores; kappa coefficients for qualitative variables ranged from 0.62 to 0.9, except for the McCabe score (kappa coefficient, 0.5).
Exposed Patients
An exposed patient was defined as having experienced nosocomial BSI after 72 h in the ICU. Nosocomial BSI was defined as onset of infection and у1 positive blood culture result unrelated to an infection incubating at ICU admission occurring Figure 1 . A chart illustrating the matching process. BSI, bloodstream infection; Day BSI, day of occurrence of BSI in the exposed patient; Day 0, corresponding day of day BSI in the unexposed patient; ICU, intensive care unit; TRIO score, Three-Day Recalibrated ICU Outcome Score [16] .
after 48 h of hospitalization in the ICU. Coagulase-negative Staphylococcus bacteremia was defined as у2 blood cultures demonstrating the same phenotype on separate occasions within a 48-h period or at least 1 blood culture positive for clinical sepsis, no other infectious process, and antibiotic treatment given by the attending physician [27] . Polymicrobial BSI was defined as the recovery of several species from у1 blood culture, with clinical evidence that all species came from the same primary focus of infection [28] . In the absence of a primary focus of infection, BSI was classified as primary. Secondary BSI was defined as recovery of the same microorganism from у1 blood culture and from a suspected source (lung, urine, intraabdominal site, soft tissue, catheter, or other). All catheter-related infections were documented by quantitative tip culture [29] . Documentation of 11 source defined multiplesource BSI. High-risk microorganisms were defined as methicillin-resistant Staphylococcus aureus (MRSA), Pseudomonas aeruginosa, Acinetobacter species, Enterobacteriaceae with extended-spectrum b-lactamase, and yeasts.
Matching Process and Unexposed Patients
Unexposed patients were patients without ICU-acquired BSI (figure 1). Matching involved selecting unexposed patients who had ICU stays that were at least as long as an exposed patient's pre-BSI stay and who had a TRIO score that differed by no more than 5%. Sample size was estimated using the approximation of Casagrande and Pike [30] . In our population, 232 patients experienced ICU-acquired BSI. Assuming that matching would be successful for 200 of these patients, to detect an OR of death of 1.4 for exposed patients, compared with unexposed patients (the equivalent of a hospital mortality rate of 25% among unexposed patients), with 80% power and a 2-sided a-risk of 5%, we needed a mean of 4 unexposed patients per exposed patient. Matching was performed using a macro procedure with SAS software (SAS) [31] . For 226 exposed patients, we found 1023 unexposed patients, with a mean of 4.5 unexposed patients per exposed patient (range, 1-5 unexposed patients per exposed patient).
The LOD score for unexposed patients was computed using the duration of ICU stay until onset of BSI in the matched exposed patient (LOD BSI), the duration of ICU stay on each of the 4 previous days (LOD BSIϪ4 to BSIϪ1), and the duration of ICU stay on each of the 4 following days (LOD BSI+1 to BSI+4).
Statistical Analysis
Only the first case of BSI after the third ICU day was included in the analysis. The characteristics of patients with and without BSIs were described using median and interquartile values for continuous variables. To determine the incidence of the first BSI, we considered being alive and discharged from the ICU after 4 days with no BSI to be a competing event. Indeed, the censor here is informative for this event, which may have a considerable influence on the incidence of BSI. Therefore, we used the cumulative incidence instead of the Kaplan-Meier method, which overestimates the incidence of the event of interest in the presence of competing events [32] . The increase in the risk of hospital death was assessed by conditional logistic regression analysis for 1:n matching, using the SAS procedure PHREG (SAS software, version 8.02; SAS Institute) in a nested exposed-unexposed study. Analyses were adjusted for potential confounding factors (i.e., factors associated with both hospital mortality and risk of BSI). We performed several a priori sensitivity analyses. To determine the influence of time on BSI onset, we compared the results of early-onset BSI (within 6 days after ICU admission) and late-onset BSI (after at least 6 days in the ICU). We also separately analyzed high-risk and low-risk microorganisms; gram-positive, gram-negative, and fungal BSI; coagulase-negative staphylococcal BSI; primary BSI; and catheter-related BSI. Finally, we compared mortality according to appropriateness of antimicrobial treatment. Results were expressed as an OR with a 95% CI. P values of !.05 were considered to be significant.
RESULTS
Patients.
The database included 3247 patients who stayed in an ICU 13 days and were monitored for the occurrence of BSI. Of blood cultures that grew coagulase-negative staphylococci, results of 182 of them were classified as false-positive by attending physicians and the steering committee and were excluded from the analysis. Nosocomial BSI occurred in 232 patients (7.1%), who constituted the study cohort. The cumulative incidence of nosocomial BSI was 1.9% on day 6 (95% CI, 1.4%-2.4%), 3.9% on day 10 (95% CI, 3.2%-4.6%), and 6.8% on day 30 (95% CI, 5.9%-7.7%). [7. 6%] of 156 episodes). Gram-negative bacteria were recovered in 68 episodes (29.3%), and gram-positive bacteria were recovered in 122 episodes (52.5%), including 50 episodes (21.5%) that were caused by coagulase-negative staphylococci (table 1) . Polymicrobial bacteremia was observed in 11.6% of cases. Antimicrobial therapy was appropriate for 147 (63.4%) of 232 patients.
Matched exposed-unexposed study. Only 6 exposed patients (2.5%) had no unexposed matches. There were 1023 unexposed matches for the 226 remaining exposed patients (table 2) . Median ICU stays among exposed and unexposed patients were 25 days (range, 16-43.5 days) and 15 days (range, 9-25 days), respectively ( ), and median hospital stays P ! .0001 were 42 days (range, 23-74 days) and 33 days (range, 19-56 days), respectively ( ). Hospital mortality was 61.5% P p .0011 among exposed patients (139 deaths among 226 patients) and 36.7% among unexposed patients (376 deaths among 1023 patients;
). Attributable mortality was 24.8%. LOD P ! .0001 score during the first 72 h in the ICU was not significantly different between exposed and unexposed patient groups, and [16] .
a Severity at admission was determined using physical and laboratory data obtained during the first 24 h after ICU admission that were most indicative of disease severity.
ICU mortality predicted by the median TRIO score was also similar (36.15% in the exposed group and 36.50% in the unexposed group; ), reflecting the matching procedure. Con-P p .2 versely, the LOD score during the 4 days before onset of BSI in exposed patients was significantly higher than that in the matched unexposed patients during the corresponding period ( figure 2 ). An even larger difference was found after BSI onset (figure 2). The only variable that was associated with both BSI and hospital mortality was the day-4 LOD score (OR, 1.10; 95% CI, 1.03-1.16;
). P p .0025 Adjustment for these prognostic variables slightly diminished the impact of BSI in the multivariable analysis. Overall, the estimated OR of hospital death among exposed patients (OR, 3.20; 95% CI, 2.30-4.43;
) decreased slightly when the P ! .0001 day-4 LOD score was taken into account (OR, 3.02; 95% CI, 2.17-4.22;
). The results remained essentially unchan-P ! .0001 Figure 2 . Logistic organ dysfunction (LOD) scores for all patients 4 days before and after onset of bloodstream infection (BSI; or the corresponding date in matched controls). All differences between exposed and unexposed patients were significant at the .001 level. Bars, 95% CIs. ) and for early-onset BSI occurring between days P ! .0001 4 and 6 in the ICU (OR, 2.57; 95% CI, 1.35-4.88;
). P p .0034 Gram-negative organisms were associated with a higher mortality than were gram-positive organisms. Patients who received adequate antibiotic therapy 11 day after blood-culture sampling had a higher hospital mortality rate than did patients treated appropriately on the same day or on the day after the culturepositive blood sample was collected (OR of 4 ). P p .0001
DISCUSSION
This large, prospective, multicenter study found that ICU-acquired BSI was associated with a 3-fold increase in the risk of hospital death. Catheter-related BSI and coagulase-negative staphylococcal BSI had no impact on mortality in our patients. Our study design differs in 3 important ways from those of earlier studies [2] [3] [4] [5] [6] [7] [8] 32] : (1) to predict ICU mortality, we considered disease severity over the first 3 ICU days; (2) we had sufficient statistical power to detect a 10% difference in mortality; and (3) our sample size was sufficiently large that we were able to investigate the influence of several covariates on mortality associated with ICU-acquired BSI.
The cumulative incidence of BSI was 6.8% on day 30 of ICU stay. The incidence rate of BSI varied from 3.2 to 6.0 [2, [33] [34] [35] between similar university and tertiary-care hospitals. The higher incidence in the current study, compared with those found in other studies, is partly ascribable to the high proportion of BSI cases due to S. aureus (20%) or coagulasenegative staphylococci (21.5%) and to the high proportion of primary BSI (32% in our study) compared with 20% [1] , 23% [2] , and 28% [36] , although 1 study [37] found an even higher proportion (47%). Our strict definition of BSI due to coagulasenegative staphylococci militates against overestimation of the number of such cases. The crude hospital mortality rate was 60%, as in other recent multicenter or single-center studies [2, 35, 39] . A crucial factor in the interpretation of results is the method used to handle confounding factors, either by matching or by adjustment. First, for matching, general severity scores determined at ICU admission (such as SAPS I [32] , SAPS II [14, 16] , MPM24 [17] , SOFA [40] , and LOD [15] ) have been found to be inaccurate for predicting the hospital mortality of patients who spend 172 h in the ICU, because only 15%-50% of ICU patients have ICU stays 172 h [9] [10] [11] [12] [13] . Using these scores to evaluate the severity of acute illness in patients exposed to BSI may introduce bias. Therefore, we matched patients in our groups on the basis of TRIO score, a composite score specifically created to deal with this situation [16] . Second, regarding adjustment, studies have shown differences in the course of severity during the ICU stay between patients who did and did not experience nosocomial infection, even when careful matching was performed at ICU admission [20, 21] . In our study, severity before the nosocomial event was a potential confounding factor, given its independent influence on both the risk of nosocomial infection and the risk of death. We chose the LOD score to measure severity over time, because this score accurately predicts hospital mortality [15] . For example, Soufir et al. [21] found that catheter-related BSI was associated with a 2-fold increase in mortality, after adjustment for variables at ICU admission. This excess mortality decreased to a nonsignificant level after controlling for the change in severity of illness between ICU admission and 1 week before the diagnosis of BSI. However, the statistical power of this study [21] was too low to rule out a small increase in the adjusted risk of death. Similarly, Digiovine et al. [8] found no increase in the risk of death in 68 cases of primary or catheter-related BSI, after adjusting for diagnosis on admission, risk exposure, age, and APACHE III prediction of mortality on the day before the diagnosis of BSI. However, increased disease severity, as assessed using APACHE III score on the day before determination of a BSI diagnosis, may be related to the first symptoms of BSI. In our study, severity of illness, as assessed by the LOD score, was significantly different between exposed and unexposed patients 4 days before onset of the nosocomial infection. It is highly unlikely that an LOD score calculated 4 days before the diagnosis of BSI is related to BSI. This minimized the risk of overmatching and, therefore, the risk of bias in our estimate of BSIrelated excess mortality. Thus, our findings suggest that future studies should take severity into account during the ICU stay to improve benchmarking strategies.
The excess risk of death differed across microorganisms, sites of infection, time to BSI, and appropriateness of therapy. The nonsignificant impact of catheter-related BSI on mortality was consonant with results obtained by Soufir et al. [21] , who used different statistical methods. The relatively low impact of catheter-related sepsis is probably ascribable in large part to the rate of BSI due to coagulase-negative staphylococci in this subgroup. BSI due to high-risk microorganisms was associated with a nearly 3-fold increase in the risk of mortality. High-risk microorganisms in our study were defined as microorganisms associated with high mortality rates in other studies [32, [37] [38] [39] [40] [41] . We found a 6-fold increase in the risk of mortality associated with gram-negative bacilli, compared with the risk of mortality associated with gram-positive microorganisms, in accordance with the results obtained by Alberti et al. [42] from a large database of unselected patients with sepsis, after adjustment for the severity of sepsis. This higher risk of mortality associated with gram-negative microorganisms was also noted in the Prowess study [43, 44] . The impact on mortality was related to the appropriateness of therapy. The short interval used for this definition in our study explains why only 63.4% of patients were recorded as having received appropriate antimicrobial treatment. Other studies used longer intervals [2, [3] [4] [5] [6] [7] 41] . We found that an interval of 11 day before initiation of appropriate antimicrobial therapy was associated with a 2-fold increase in the risk of death. These results have important implications both for evaluating the impact of new drugs on mortality associated with sepsis and for benchmarking. Thus, our findings indicate that future studies will have to separate patients with catheter-related BSI from patients with coagulasenegative staphylococcal BSI, because these groups have different risks of death. To assess the quality of care in ICUs, it would be interesting to focus on subgroups of BSIs rather than on the overall BSI population. Catheter-related BSI might be the best indicator.
In conclusion, by using a carefully designed matching procedure, this multicenter study found that ICU-acquired BSI was associated with a 3-fold increase in mortality, with considerable differences across microorganisms, sites, and time to BSI. Taking into account these differences in future quality-ofcare programs might improve benchmarking.
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